雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Practical use of Ra223 treatment:real world of Xofigo® therapy for prostate cancer Hiroji Uemura 1 1Department of Urology and Renal Transplantation Yokohama City University Medical Center Keyword: 前立腺癌 , ラジウム223 , α線放射能治療 , 骨転移 pp.1017-1026
Published Date 2020/8/10
DOI https://doi.org/10.18888/rp.0000001358
  • Abstract
  • Look Inside
  • Reference

It is well known that the most frequent sites of metastasis in patients with advanced prostate cancer is bone with osteoblastic change. Most castration resistant prostate cancer(CRPC)patients suffer from bone metastasis. Radium223(Ra223)dichloride emits α particles and has been proven to improve overall survival and QOL by reducing symptomatic skeletal symptoms in metastatic CRPC patients. In practice, the timing of Ra223 treatment has become important because there are several CRPC therapies such as hormonal or cytotoxic agents. The completion of 6 cycles of Ra223 is critical for prolonging OS. The optimal timing of Ra223 administration is recommended the duration prior to chemotherapy.


Copyright © 2020, KANEHARA SHUPPAN Co.LTD. All rights reserved.

基本情報

電子版ISSN 印刷版ISSN 0009-9252 金原出版

関連文献

もっと見る

文献を共有